\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\\.\ \(14\)\
\-\ n\\/a\ \(127\)\
\-\ calcified\\ mass\\ lesions\\ in\\ the\\ left\\ and\\ right\\ hepatic\\ lobes\\.\\ \\ additional\\ blastic\\ lesions\\ are\\ present\\ in\\ multiple\\ vertebral\\ bodies\\ and\\ in\\ the\\ pelvis\\.\ \(0\)\
\-\ metastatic\\ medullary\\ thyroid\\ cancer\ \(0\)\
\-\ metastatic\\ disease\\:\ \(0\)\
\-\ 1\\.\\ mucinous\\ carcinoma\\ of\\ colon\\,\\ breast\\,\\ or\\ stomach\ \(0\)\
\-\ 2\\.\\ ovarian\\ carcinoma\ \(0\)\
\-\ 3\\.\\ melanoma\\,\\ osteosarcoma\\,\\ carcinoid\\,\\ leiomyosarcoma\\,\\ thyroid\ \(0\)\
\-\ benign\\ tumors\\:\ \(0\)\
\-\ 1\\.\\ cavernous\\ hemangioma\ \(0\)\
\-\ 2\\.\\ congenital\\ cyst\ \(0\)\
\-\ vascular\\:\ \(28\)\
\-\ 1\\.\\ hematoma\ \(0\)\
\-\ 2\\.\\ calcified\\ hepatic\\ artery\\ aneurysms\ \(0\)\
\-\ infection\\:\ \(1\)\
\-\ 1\\.\\ chronic\\ granulomatous\\ disease\\ of\\ childhood\ \(0\)\
\-\ 2\\.\\ tuberculosis\\ or\\ histo\ \(0\)\
\-\ 3\\.\\ old\\ pyogenic\\ or\\ amebic\\ abscesses\ \(0\)\
\-\ 39\\ yo\\ african\\ american\\ male\\ with\\ history\\ of\\ subtotal\\ thyroidectomy\\ in\\ 1995\\ due\\ to\\ medullary\\ thyroid\\ cancer\\.\ \(0\)\
\-\ given\\ both\\ calcified\\ liver\\ masses\\ and\\ blastic\\ bony\\ metastases\\,\\ ddx\\ becomes\\ more\\ limited\\ to\\ metastatic\\ tumors\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ blastic\\:\\ 0\\.09943409665606798\ \(0\)\
\-\ calcified\\:\\ 0\\.084000548408085\ \(0\)\
\-\ 2\\.\\:\\ 0\\.08297539364275597\ \(0\)\
\-\ 1\\.\\:\\ 0\\.08150195927626262\ \(0\)\
\-\ thyroid\\:\\ 0\\.08020562850972619\ \(0\)\
\-\ medullary\\:\\ 0\\.06268684309395671\ \(0\)\
\-\ hepatic\\:\\ 0\\.05448082979856507\ \(0\)\
\-\ histo\\:\\ 0\\.0524397578237495\ \(0\)\
\-\ amebic\\:\\ 0\\.0524397578237495\ \(0\)\
\-\ metastatic\\:\\ 0\\.049262047411055505\ \(0\)\
\-\ tumors\\:\\ 0\\.049003303170541995\ \(0\)\
\-\ subtotal\\:\\ 0\\.04771426768324397\ \(0\)\
\-\ 3\\.\\:\\ 0\\.04463930094871339\ \(0\)\
\-\ thyroidectomy\\:\\ 0\\.04442584847643135\ \(0\)\
\-\ leiomyosarcoma\\:\\ 0\\.04303408086731719\ \(0\)\
\-\ cancer\\:\\ 0\\.04288801930327886\ \(0\)\
\-\ pyogenic\\:\\ 0\\.04242306783164134\ \(0\)\
\-\ 1995\\:\\ 0\\.04037525114007891\ \(0\)\
\-\ mucinous\\:\\ 0\\.03913464862482871\ \(0\)\
\-\ aneurysms\\:\\ 0\\.03913464862482871\ \(0\)\
\-\ carcinoid\\:\\ 0\\.038762204623535336\ \(0\)\
\-\ carcinoma\\:\\ 0\\.03697599496207429\ \(0\)\
\-\ abscesses\\:\\ 0\\.036843773873299415\ \(0\)\
\-\ childhood\\:\\ 0\\.036703704112473486\ \(0\)\
\-\ lesions\\:\\ 0\\.03492458788311371\ \(0\)\
\-\ \\:\\:\\ 0\\.034512208121852364\ \(0\)\
\-\ ddx\\:\\ 0\\.034438575043987237\ \(0\)\
\-\ becomes\\:\\ 0\\.03413521375658637\ \(0\)\
\-\ african\\:\\ 0\\.03403671448302982\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.033939470011446385\ \(0\)\
\-\ melanoma\\:\\ 0\\.03329138265429763\ \(0\)\
\-\ granulomatous\\:\\ 0\\.03148221787585767\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.031073177829032426\ \(0\)\
\-\ american\\:\\ 0\\.031073177829032426\ \(0\)\
\-\ bodies\\:\\ 0\\.03055980205033649\ \(0\)\
\-\ 39\\:\\ 0\\.03031550639319013\ \(0\)\
\-\ cavernous\\:\\ 0\\.030255634809518175\ \(0\)\
\-\ ovarian\\:\\ 0\\.02984918813380205\ \(0\)\
\-\ hemangioma\\:\\ 0\\.029147375192384604\ \(0\)\
\-\ stomach\\:\\ 0\\.028844013904983732\ \(0\)\
\-\ lobes\\:\\ 0\\.028745514631427185\ \(0\)\
\-\ metastases\\:\\ 0\\.027868186641549497\ \(0\)\
\-\ limited\\:\\ 0\\.027526963901718146\ \(0\)\
\-\ additional\\:\\ 0\\.026156081634732802\ \(0\)\
\-\ bony\\:\\ 0\\.026086684904188896\ \(0\)\
\-\ vertebral\\:\\ 0\\.025815239850475253\ \(0\)\
\-\ colon\\:\\ 0\\.025617808471926254\ \(0\)\
\-\ breast\\:\\ 0\\.024065327815500397\ \(0\)\
\-\ congenital\\:\\ 0\\.023856175340781965\ \(0\)\
\-\ pelvis\\:\\ 0\\.023702987836577316\ \(0\)\
\-\ n\\/a\\:\\ 0\\.023627531659229668\ \(0\)\
\-\ hematoma\\:\\ 0\\.02321348762154267\ \(0\)\
\-\ or\\:\\ 0\\.022935635472451317\ \(0\)\
\-\ benign\\:\\ 0\\.022511834862848863\ \(0\)\
\-\ liver\\:\\ 0\\.022490240540707813\ \(0\)\
\-\ given\\:\\ 0\\.022361941927605666\ \(0\)\
\-\ masses\\:\\ 0\\.02205032364882509\ \(0\)\
\-\ available\\:\\ 0\\.021929153044578605\ \(0\)\
\-\ vascular\\:\\ 0\\.0213878112055244\ \(0\)\
\-\ disease\\:\\ 0\\.021324237270468765\ \(0\)\
\-\ yo\\:\\ 0\\.01962863758246383\ \(0\)\
\-\ artery\\:\\ 0\\.019423893069528235\ \(0\)\
\-\ infection\\:\\ 0\\.01896195858070845\ \(0\)\
\-\ chronic\\:\\ 0\\.018373966663412213\ \(0\)\
\-\ cyst\\:\\ 0\\.017529550656687806\ \(0\)\
\-\ due\\:\\ 0\\.017406695824067477\ \(0\)\
\-\ both\\:\\ 0\\.01665801519607726\ \(0\)\
\-\ more\\:\\ 0\\.016314322971848597\ \(0\)\
\-\ present\\:\\ 0\\.014732891251386876\ \(0\)\
\-\ \\,\\:\\ 0\\.014465423348251997\ \(0\)\
\-\ multiple\\:\\ 0\\.013738977125795946\ \(0\)\
\-\ in\\:\\ 0\\.012867090996649006\ \(0\)\
\-\ male\\:\\ 0\\.011795462121278421\ \(0\)\
\-\ not\\:\\ 0\\.009426096730854467\ \(0\)\
\-\ mass\\:\\ 0\\.009072221427080645\ \(0\)\
\-\ history\\:\\ 0\\.009009271280206742\ \(0\)\
\-\ are\\:\\ 0\\.008892166965874823\ \(0\)\
\-\ left\\:\\ 0\\.007298513505900112\ \(0\)\
\-\ right\\:\\ 0\\.006882684802369593\ \(0\)\
\-\ old\\:\\ 0\\.0066788900523836224\ \(0\)\
\-\ to\\:\\ 0\\.006520123793022691\ \(0\)\
\-\ and\\:\\ 0\\.00412234364272256\ \(0\)\
\-\ of\\:\\ 0\\.0026680259724730176\ \(0\)\
\-\ the\\:\\ 0\\.0021106761023454317\ \(0\)\
\-\ \\.\\:\\ 0\\.0013549441258529113\ \(0\)\
\-\ with\\:\\ 0\\.0008931616495411429\ \(0\)\
